Abstract
Aims: To investigate the effects of Y-box protein 1 (YB-1) on the mitogen-activated protein kinase pathway to ascertain which signaling pathway is involved in YB-1-induced mesangial cell (MC) proliferation. Methods: The rat MC line HBZY-1 was transfected with pcDNA3.1-YB-1. Cell proliferation was determined by [3H]thymidine incorporation, cell counting and cell-cycle analysis. The expression of cyclins was examined by real-time RT-PCR and immunoblotting analysis. Phosphorylation of c-Raf, MEK1/2, and ERK1/2 was detected by immunoblotting analysis. Results: MCs transfected with YB-1 showed an increased DNA synthesis and number of cells in the S and G2 phases of the cell cycle. The expression of cyclins (cyclin A2, cyclin D1, cyclin E and p27) was increased, while p21 levels were decreased. The expression levels of phosphorylated c-Raf kinase, MEK1/2 and the ERK1/2 proteins were elevated in MCs transfected with YB-1. YB-1-stimulated cell proliferation was blocked by U0126, a specific inhibitor of ERK1/2. ERK1/2 regulated YB-1 expression in MCs stimulated with TGF-β, an effect that was inhibited by U0126. Conclusions: YB-1 has an apparent stimulatory effect on c-Raf, MEK1/2, ERK1/2 and cell-cycle progression in MCs, after which activated ERK1/2 goes on to upregulate YB-1 expression and augment the proliferative effect of YB-1.
Journal Section:
Original Paper
References
1.
Johnson RJ: The glomerular response to injury: progression or resolution? Kidney Int 1994;45:1769–1782.
[PubMed]
2.
Abboud HE: Growth factors in glomerulonephritis. Kidney Int 1993;43:252–267.
[PubMed]
3.
Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 1993;39(suppl):S47–S54.
4.
Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1993;4:119–128.
[PubMed]
5.
Hunter T, Pines J: Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573–582.
[PubMed]
6.
Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059–1065.
[PubMed]
7.
Hunter T: Braking the cycle. Cell 1993;75:839–841.
[PubMed]
8.
Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323–330.
[PubMed]
9.
Bokemeyer D, Panek D, Kitahara M, Trzaskos JM, Muller CE, Hockemeyer J, Kunter U, Boor P, Floege J, Kramer HJ, Ostendorf T: The MAP kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. Nephrol Dial Transplant 2007;22:3431–3441.
[PubMed]
10.
Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ: Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997;100:582–588.
[PubMed]
11.
Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153–183.
[PubMed]
12.
Yoon S, Seger R: The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006;24:21–44.
[PubMed]
13.
Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD: Characterization of the CDNA encoding a protein binding to the major histocompatibility complex class II Y-box. Proc Natl Acad Sci USA 1988;85:7322–7326.
[PubMed]
14.
Swamynathan SK, Nambiar A, Guntaka RV: Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J 1998;12:515–522.
[PubMed]
15.
Ladomery M, Sommerville J: A role for Y-box proteins in cell proliferation. Bioessays 1995;17:9–11.
[PubMed]
16.
Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, Yoshida T, Matsuo K, Miyamoto N, Izumi H: Transcription factors and drug resistance. Eur J Cancer 2005;41:2577–2586.
[PubMed]
17.
Van Roeyen CR, Eitner F, Martinkus S, Thieltges SR, Ostendorf T, Bokemeyer D, Luscher B, Luscher-Firzlaff JM, Floege J, Mertens PR: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005;16:2985–2996.
[PubMed]
18.
Zhang A, Ding G, Huang S, Wu Y, Pan X, Guan X, Chen R, Yang T: C-jun NH2-terminal kinase mediation of angiotensin ii-induced proliferation of human mesangial cells. Am J Physiol Renal Physiol 2005;288:F1118–F1124.
[PubMed]
19.
Zhang A, Jia Z, Guo X, Yang T: Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 2007;293:F723–F731.
[PubMed]
20.
Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149–1163.
[PubMed]
21.
Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 1996;274:1664–1672.
[PubMed]
22.
Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807–869.
[PubMed]
23.
Bokemeyer D, Sorokin A, Dunn MJ: Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996;49:1187–1198.
[PubMed]
24.
Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res 1996;78:947–953.
[PubMed]
25.
Shibao K, Takano H, Nakayama Y, Okazaki K, Nagata N, Izumi H, Uchiumi T, Kuwano M, Kohno K, Itoh H: Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas. Int J Cancer 1999;83:732–737.
[PubMed]
26.
Shankland SJ: Cell-cycle control and renal disease. Kidney Int 1997;52:294–308.
[PubMed]
27.
Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 1997;8:51–60.
[PubMed]
28.
Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996;50:1230–1239.
[PubMed]
29.
Qiu LQ, Sinniah R, Hsu SI: Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy. Lab Invest 2004;84:1112–1125.
[PubMed]
30.
Wolf G, Reinking R, Zahner G, Stahl RA, Shankland SJ: Erk-1/2 phosphorylates p27(kip1): functional evidence for a role in high glucose-induced hypertrophy of mesangial cells. Diabetologia 2003;46:1090–1099.
[PubMed]
31.
Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000;278:F515–F529.
[PubMed]
32.
Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ: The cyclin-dependent kinase inhibitor p27kip1 safeguards against inflammatory injury. Nat Med 1998;4:575–580.
[PubMed]
33.
Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ: Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 1999;103:597–604.
[PubMed]
34.
Capowski EE, Esnault S, Bhattacharya S, Malter JS: Y-box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001;167:5970–5976.
[PubMed]
35.
Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M: Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000;14:1236–1248.
[PubMed]
36.
Evdokimova V, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP, Sonenberg N: The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J 2001;20:5491–5502.
[PubMed]
37.
Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J, Triche TJ, Sonenberg N, Sorensen PH: Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 2006;26:277–292.
[PubMed]
38.
Coles LS, Lambrusco L, Burrows J, Hunter J, Diamond P, Bert AG, Vadas MA, Goodall GJ: Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3β and repression of the human VEGF promoter. FEBS Lett 2005;579:5372–5378.
[PubMed]
39.
Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP: YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining. Mol Cell Biol 2005;25:3317–3323.
[PubMed]
© 2009 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2009
You do not currently have access to this content.
